2025. Ligand-based drug design studies of different flavonoids as a potential inhibitor of BCR-ABL. UCP Journal of Science & Technology. 3, 1 (Dec. 2025), 29–45. DOI:https://doi.org/10.24312/ucp-jst.03.01.704.